About Us
Founded in 2007 in Tianjin Binhai New Area, Tianjin Binhai Venture Capital Investment Management Co., Ltd. is an investment management firm focused on biomedicine and other high technology sectors.
Our management team brings international experience and more than a decade of expertise in venture capital, private equity, primary market investments, IPOs, and mergers and acquisitions.Combining deep technical understanding with industry insight, we have built extensive networks across domestic and international financial markets and industries.
About Us
Biomedicine
We invest in companies engaged in the research, development, application, and commercialization of innovative technologies, products, and solutions across the healthcare industry. Our primary focus is on oncology related fields, including novel drug development, innovative therapies, diagnostic technologies, and related products.
Innovative Technologies
We invest in companies developing innovative technologies in the fields of information technology, telecommunications, artificial intelligence, robotics, and the internet industry.
Cross-border Investment
Our partners and we invest in biomedicine and innovative technology companies in the United States and Europe, as well as in companies engaged in the licensing and introduction of technologies from European and American companies into the Chinese market, such as pharmaceutical License-in transactions and China rights partnerships.
Biomedicine
We invest in companies engaged in the research, development, application, and commercialization of innovative technologies, products, and solutions across the healthcare industry. Our primary focus is on oncology related fields, including novel drug development, innovative therapies, diagnostic technologies, and related products.
Innovative Technologies
We invest in companies developing innovative technologies in the fields of information technology, telecommunications, artificial intelligence, robotics, and the internet industry.
Cross-border Investment
Our partners and we invest in biomedicine and innovative technology companies in the United States and Europe, as well as in companies engaged in the licensing and introduction of technologies from European and American companies into the Chinese market, such as pharmaceutical License-in transactions and China rights partnerships.
NEWS
News and Information
News and information to share with you
Accendatech Co., Ltd. Files for IPO Tutoring with CICC
Accendatech Co., Ltd. has recently completed the filing for IPO tutoring with the Tianjin Office of the China Securities Regulatory Commission (CSRC). China International Capital Corporation (CICC) has been appointed as the company's IPO tutoring institution.
View DetailsNEWS
News and Information
News and information to share with you
Accendatech Co., Ltd. Files for IPO Tutoring with CICC
Accendatech Co., Ltd. has recently completed the filing for IPO tutoring with the Tianjin Office of the China Securities Regulatory Commission (CSRC). China International Capital Corporation (CICC) has been appointed as the company's IPO tutoring institution.
View Details
Listing Criteria for the STAR Market
To be listed on the Science and Technology Innovation Board, a company must have been in continuous operation for more than 3 years, meet the requirements for science and technology innovation attributes, have a share capital of no less than 30 million yuan after issuance, meet one of the relevant financial indicators for market capitalization matching, and be compliant with regulations and free from major violations.
View Details
A Comparison of Listing Sectors on the Shenzhen Stock Exchange and the Shanghai Stock Exchange
A comparison of listing on the Shenzhen Stock Exchange and the Shanghai Stock Exchange, covering aspects such as the listing entity's eligibility, independence, standardized operation, finance and accounting, use of raised funds, share capital and public offering ratio, shareholder commitments, and information disclosure.
View Details
Listing Requirements of The Stock Exchange of Hong Kong Limited
The Stock Exchange of Hong Kong Ltd. main board requires meeting one of three financial standards, including having a three-year operating record, while the requirements for the GEM board are slightly lower; there are public shareholding ratio requirements, and special companies have corresponding listing rules.
View Details
Copyright © Tianjin Binhai Venture Capital Investment Management Co., Ltd.
Technical Support: Jinkun Technology. This website supports IPv6
Address: Building B1, OVU China Electronics Technology Innovation Park, 122 Yingshui Road, Xiqing District, Tianjin, China, 300041
Email: office@binhaicapital.com
Partner
Copyright © Tianjin Binhai Venture Capital Management Co., Ltd. This site supports IPv6
Technical Support: Jinkun Technology
中文
English
